FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Evoq Remedies IPO and p e-analytics-ipo.
Evoq Remedies IPO is a SME Book Built Issue IPO proposed to list at BSE SME while p e-analytics-ipo is a SME Book Built Issue proposed to list at NSE SME.
Evoq Remedies IPO | p e-analytics-ipo | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price Issue | Book Built Issue |
Listing At | BSE SME | NSE SME |
Lead Managers | Swastika Investmart Ltd | Sarthi Capital Advisors Private Limited |
Registrar | Bigshare Services Pvt Ltd | Bigshare Services Pvt Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Evoq Remedies IPO is up to ₹9.72 Cr whereas the issue size of the p e-analytics-ipo is up to ₹31.60 Cr. The final issue price of Evoq Remedies IPO is ₹27.00 per share and of p e-analytics-ipo is ₹114.00 per share.
Evoq Remedies IPO | p e-analytics-ipo | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹111.00 per share | |
Issue Price (Upper) | ₹114.00 per share | |
Issue Price (Final) | ₹27.00 per share | ₹114.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 4000 shares | 1200 shares |
Fresh Issue Size | 36,00,000 shares | 14,52,000 shares |
Fresh Issue Size (Amount) | up to ₹9.72 Cr | up to ₹16.55 Cr |
OFS Issue Size | 13,20,000 shares | |
OFS Issue Size (Amount) | up to ₹15.05 Cr | |
Issue Size Total | 36,00,000 shares | 27,72,000 shares |
Issue Size Total (Amount) | up to ₹9.72 Cr | up to ₹31.60 Cr |
Evoq Remedies IPO opens on Mar 17, 2022, while p e-analytics-ipo opens on Mar 22, 2022. The closing date of Evoq Remedies IPO and p e-analytics-ipo is Mar 22, 2022, and Mar 25, 2022, respectively.
Evoq Remedies IPO | p e-analytics-ipo | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Mar 17, 2022 | Mar 22, 2022 |
Issue Close | Mar 22, 2022 | Mar 25, 2022 |
Basis Of Allotment (Tentative) | Mar 25, 2022 | Mar 30, 2022 |
Initiation of Refunds (Tentative) | Mar 28, 2022 | Mar 31, 2022 |
Credit of Share (Tentative) | Mar 29, 2022 | Apr 01, 2022 |
Listing date (Tentative) | Mar 30, 2022 | Apr 04, 2022 |
Anchor Lockin End date 1 | Apr 24, 2022 | Apr 29, 2022 |
Anchor Lockin End date 2 | Jun 23, 2022 | Jun 28, 2022 |
Evoq Remedies IPO P/E ratio is 33.75, as compared to p e-analytics-ipo P/E ratio of 14.56.
Evoq Remedies IPO | p e-analytics-ipo | |||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 99.99% | 96.11% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 73.53% | 70.20% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 33.75 | 14.56 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹36.72 Cr. | ₹119.50 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Evoq Remedies IPO retail investors (RII) are offered 17,10,000 shares while in p e-analytics-ipo retail investors are offered 17,10,000 shares. Qualified institutional buyers (QIB) are offered in Evoq Remedies IPO and 13,15,200 shares in p e-analytics-ipo.
Evoq Remedies IPO | p e-analytics-ipo | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | 1,80,000 shares | 1,39,200 shares |
QIB | 13,15,200 shares | |
NII | 17,10,000 shares | 3,96,000 shares |
RII | 17,10,000 shares | 9,21,600 shares |
Employee | ||
Others | ||
Total | 34,20,000 shares | 26,32,800 shares |
Evoq Remedies IPO subscribed 1.67x in total, whereas p e-analytics-ipo subscribed 46.34x.
Evoq Remedies IPO | p e-analytics-ipo | |
---|---|---|
QIB (times) | 13.22x | |
NII (times) | 0.30x | 126.40x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 3.03x | 59.20x |
Employee (times) | ||
Other (times) | ||
Total (times) | 1.67x | 46.34x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|